Sort by:
Keyphrases
Chemoresistance
100%
Redox Status
100%
CD31
100%
Angiosarcoma
100%
Doxorubicin
22%
YAP Signaling
22%
Endothelial Differentiation
22%
Expression Level
11%
Small Interfering RNA (siRNA)
11%
Reactive Oxygen Species
11%
Detoxification
11%
Cell Viability
11%
Apoptosis Induction
11%
Antioxidant Enzymes
11%
Biological Function
11%
Cell Population
11%
Colony Formation
11%
Clinical Samples
11%
Rational Development
11%
Endothelial Cells
11%
Growth Induction
11%
Redox
11%
Growth Suppression
11%
Nuclear Accumulation
11%
Apoptosis Inhibition
11%
Oxidative Stress Damage
11%
Soft Tissue Sarcoma
11%
Chemoresistant
11%
Endothelial Tube Formation
11%
Constitutive Expression
11%
Cell Subsets
11%
Pazopanib
11%
Oxidative DNA Damage
11%
Endothelial Adhesion
11%
PECAM-1
11%
Novel Combination Therapy
11%
Adhesion Receptors
11%
Blocking Antibodies
11%
Medicine and Dentistry
Drug Resistance
100%
Angiosarcoma
100%
Doxorubicin
22%
Combination Therapy
11%
Downregulation
11%
Cell Line
11%
Programmed Cell Death
11%
Oxidative Stress
11%
Cell Population
11%
Reactive Oxygen Species
11%
Endothelial Cell
11%
Cell Viability
11%
Small Interfering RNA
11%
Antioxidant
11%
Biological Functions
11%
Growth Inhibition
11%
Colony Formation
11%
DNA Damage
11%
Soft Tissue Sarcoma
11%
Enhancer Region
11%
Adhesion Receptor
11%
Platelet Endothelial Cell Adhesion Molecule 1
11%
Blocking Antibody
11%
Detoxication
11%
Pazopanib
11%
Veterinary Science and Veterinary Medicine
Angiosarcoma
100%
Doxorubicin
22%
Soft-Tissue Sarcoma
11%
Oxidative Stress
11%